A New Antidiabetic Agent Showing Short- and Long-Term Effects Due to Peroxisome Proliferator-Activated Receptor Alpha/Gamma Dual Agonism and Mitochondrial Pyruvate Carrier Inhibition
Antonio Laghezza(University of Bari Aldo Moro), Fulvio Loiodice(University of Bari Aldo Moro), Paolo Tortorella(University of Bari Aldo Moro), Paolo Paoli(University of Florence), Sudeep Ca, Ashok Pattnaik(Birla Institute of Technology, Mesra), Suhas Tambe(TCG Lifesciences (India)), Ravi Pratap Singh(Birla Institute of Technology, Mesra), Luca Piemontese(University of Bari Aldo Moro), Alice Santi(European Society for Sexual Medicine), Rosalba Leuci(University of Bari Aldo Moro), Venkatesan Jayaprakash(Birla Institute of Technology, Mesra), Abanish Biswas(Birla Institute of Technology, Mesra), Massimo Genovese(University of Florence), Antonio Lavecchia(Federico II University Hospital), Erica Pranzini(University of Florence), Leonardo Brunetti(University of Bari Aldo Moro), Carmen Cerchia(Federico II University Hospital)
Cited by 8
Related Papers
Morin: A Promising Natural Drug
|Current Medicinal Chemistry|2016|249
Cancer Associated Fibroblasts: The Architects of Stroma Remodeling
|PROTEOMICS|2017|247
Tumor matrix stiffness promotes metastatic cancer cell interaction with the endothelium
|The EMBO Journal|2017|201
Dietary Polyphenols: Review on Chemistry/Sources, Bioavailability/Metabolism, Antioxidant Effects, and Their Role in Disease Management
|Antioxidants|2024|192
The insulin-mimetic effect of Morin: A promising molecule in diabetes treatment
|Biochimica et Biophysica Acta (BBA) - General Subjects|2013|134